These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.
7. Parameters governing steam sterilization of deadlegs. Young JH; Ferko BL; Gaber RP J Pharm Sci Technol; 1994; 48(3):140-7. PubMed ID: 8069515 [TBL] [Abstract][Full Text] [Related]
8. Studies on microbial contamination of infusion fluids arising from drug additions and administration. Ernerot L; Thorén S; Sandell E Acta Pharm Suec; 1973 May; 10(2):141-6. PubMed ID: 4728099 [No Abstract] [Full Text] [Related]
9. PDA presentation at FDA Open Conference on Sterile Drug Manufacturing. Parenteral Drug Association. J Pharm Sci Technol; 1994; 48(1):4-6. PubMed ID: 8004417 [No Abstract] [Full Text] [Related]
10. Studies on microbiological contamination of in-use IV-fluids. Stjernström G; Gunnarsson B; Wikner H Acta Pharm Suec; 1978; 15(3):169-74. PubMed ID: 362822 [No Abstract] [Full Text] [Related]
11. Validation of moist heat sterilization processes: cycle design, development, qualification and ongoing control. Parenteral Drug Association PDA J Pharm Sci Technol; 2007; 61(1 Suppl TR1):2-51. PubMed ID: 17966927 [No Abstract] [Full Text] [Related]
12. Letter: Addition of drugs to intravenous fluids. Lancet; 1976 Apr; 1(7964):858. PubMed ID: 56671 [No Abstract] [Full Text] [Related]
13. Contaminated drip fluid. Stuttaford T Br Med J; 1972 Jul; 3(5818):112. PubMed ID: 5041122 [No Abstract] [Full Text] [Related]
14. Contaminated drip fluid. Ford PG Br Med J; 1972 Apr; 2(5805):111. PubMed ID: 5018290 [No Abstract] [Full Text] [Related]
15. An approach to establishing parenteral solution sterilization cycles. Korczynski MS; Peterson CL; Loshbaugh CC Bull Parenter Drug Assoc; 1974; 28(6):270-7. PubMed ID: 4455323 [No Abstract] [Full Text] [Related]
16. The potential for use of steam at atmospheric pressure to decontaminate or sterilize parenteral filling lines incorporating barrier isolation technology. Lysfjord JP; Haas PJ; Melgaard HL; Pflug IJ PDA J Pharm Sci Technol; 1995; 49(5):212-9. PubMed ID: 7489194 [TBL] [Abstract][Full Text] [Related]
17. [Insoluble contaminants in large-volume parenteral solutions. III. Effect of drug containers and sterilization]. Pawlaczyk J; Nowacka D Acta Pol Pharm; 1983; 40(2):199-206. PubMed ID: 6659998 [No Abstract] [Full Text] [Related]
18. Parenteral fundamentals. Basic principles and applications of bioindicators. Myers T; Chrai S J Parenter Drug Assoc; 1980; 34(3):234-43. PubMed ID: 6901777 [No Abstract] [Full Text] [Related]